stockrowAdaptive Biotechnologies Corporation (ADPT) vs GRAIL, Inc. (GRAL)
- Adaptive Biotechnologies Corporation ADPT 27.17 +1.27%
- GRAIL, Inc. GRAL 125.01 +4.94%
Adaptive Biotechnologies Corporation and GRAIL, Inc. are both Diagnostics & Research companies. GRAIL, Inc. is the larger, with a market value of $5.3B against $4.3B — 1.2× the size. Adaptive Biotechnologies Corporation grew revenue faster over the last twelve months: 17.9% against 17.5%. Adaptive Biotechnologies Corporation has the higher net margin (−23.7% vs −243.8%) and the higher return on invested capital (0.00% vs −14.7%). Across the 16 metrics below, Adaptive Biotechnologies Corporation leads on 11 and GRAIL, Inc. on 5.
Valuation
Profitability
| Metric | ADPT | GRAL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 74.15% | 0.00% | 48.32% |
| Operating margin | (16.18%) | (347.28%) | (5.68%) |
| Net margin | (23.66%) | (243.80%) | (4.10%) |
| Free cash flow margin | (2.96%) | (187.27%) | 0.00% |
| Return on equity | (36.34%) | (17.31%) | 0.00% |
| Return on assets | (12.02%) | (15.24%) | (6.05%) |
| Return on invested capital | 0.00% | (14.74%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack